Calcineurin and matrix protein expression in cardiac hypertrophy: Evidence for calcineurin B to control excessive hypertrophic signaling

Basic Research in Cardiology

Volumn 101, Issue 4, 2006, Pages 292-300

  Grammer, Joachim Burkhard ^a   Bleiziffer, Sabine ^a   Monticelli, Fabio ^b   Lange, Rüdiger ^a   Bauernschmitt, Robert ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF SALZBURG   (Austria)

Author keywords

Calcineurin signaling; Compensated left ventricular hypertrophy; Matrix metalloproteinases; Tissue inhibitors of matrix metalloproteinases

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CALCINEURIN; GELATIN; GELATINASE B; MATRIX PROTEIN; MESSENGER RNA; PROTEIN SUBUNIT; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TRANSCRIPTION FACTOR NFAT;

ADULT; AGED; AORTA STENOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ATRIAL NATRIURETIC FACTOR; CALCINEURIN; CALCIUM; DOWN-REGULATION; EXTRACELLULAR MATRIX; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 33745235149     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00395-006-0598-z     Document Type: Article

References (29)

1. Abbasi S, Lee JD, Su B, Chang X, Alcon J, Yang J, Kellems RE, Xia Y (2006) Protein kinase mediated regulation of calcineurin through the phosphorylation of modulatory calcineurin interacting protein 1. J Biol Chem Jan 16; [Epub ahead of print]
2. Bueno OF, Lips DJ, Kaiser RA, Wilkins BJ, Dai YS, Glascock BJ, Klevitsky R, Hewett TE, Kimball TR, Aronow BJ, Doevendans PA, Molkentin JD (2004) Calcineurin Aβ gene targeting predisposes the myocardium to acute ischemia-induced apoptosis and dysfunction. Circ Res 94:91-99
3. Bueno OF, Wilkins BJ, Tymitz KM, Glascock BJ, Kimball TF, Lorenz JN, Molkentin JD (2002) Impaired cardiac hypertrophic response in Calcineurin Aβ -deficient mice. Proc Natl Acad Sci USA 99:4586-4591
4. Burkard N, Becher J, Heindl C, Neyses L, Schuh K, Ritter O (2005) Targeted proteolysis sustains calcineurin activation. Circulation 111:1045-1053
5. Diedrichs H, Chi M, Boelck B, Mehlhorn U, Schwinger RH (2004) Increased regulatory activity of the calcineurin/NFAT pathway in human heart failure. Eur J Heart Fail 6:3-9
6. Grammer JB, Böhm J, Dufour A, Benz M, Lange R, Bauernschmitt R (2005) Atrial fibrosis in heart surgery patients. Decreased collagen III/ I ratio in postoperative atrial fibrillation. Basic Res Cardiol 100:288-294
7. Grammer JB, Bosch RF, Kühlkamp V, Seipel L (2000) Molecular remodeling of Kv4.3 potassium channels in human atrial fibrillation. J Cardiovasc Electrophysiol 11:626-633
8. Hannan RD, Jenkins A, Jenkins AK, Brandenburger Y (2003) Cardiac hypertrophy: A matter of translation. Clin Exp Pharmacol Physiol 30:517-527
9. Harris CD, Ermak G, Davies KJ (2005) Multiple roles of the DSCR1 (Adapt78 or RCAN1) gene and its protein product calcipressin 1 (or RCAN1) in disease. Cell Mol Life Sci 62:2477-2486
10. Hubbard MJ, Klee CB (1989) Functional domain structure of calcineurin A: mapping by limited proteolysis. Biochemistry 28:1868-1874
11. Iwanaga Y, Aoyama T, Kihara Y, Onozawa Y, Yoneda T, Sasayama S (2002) Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats. J Am Coll Cardiol 39:1384-1391
12. Kupari M, Turto H, Lommi J (2005) Left ventricular hypertrophy in aortic valve stenosis: Preventive or promotive of systolic dysfunction and heart failure? Eur Heart J 26:1790-1796
13. Li YY, Feldman AM, Sun Y, McTiernan CF (1998) Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. Circulation 98:1728-1734
14. Li YY, McTiernan CF, Feldman AM (2000) Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc Res 46:214-224
15. Lips DJ, de Windt LJ, van Kraaij DJ, Doevendans PA (2003) Molecular determinants of myocardial hypertrophy and failure: Alternative pathways for beneficial and maladaptive hypertrophy. Eur Heart J 24:883-896
16. Molkentin JD (2004) Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Cardiovasc Res 63:467-475
17. Noji Y, Shimizu M, Ino H, Higashikata T, Yamaguchi M, Nohara A, Horita T, Shimizu K, Ito Y, Matsuda T, Namura M, Mabuchi H (2004) Increased circulating matrix metalloproteinase-2 in patients with hypertrophic cardiomyopathy with systolic dysfunction. Circ J 68:355-360
18. Oka T, Dai YS, Molkentin JD (2005) Regulation of calcineurin through transcriptional induction of the calcineurin A beta promoter in vitro and in vivo. Mol Cell Biol 25:6649-6659
19. Polyakova V, Hein S, Kostin S, Ziegelhoeffer T, Schaper J (2004) Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression. J Am Coll Cardiol 44:1609-1618
20. Ritter O, Hack S, Schuh K, Röthlein N, Perrot A, Osterziel KJ, Schulte HD, Neyses L (2002) Calcineurin in human heart hypertrophy. Circulation 105:2265-2269
21. Rothermel BA, Vega RB, Williams RS (2003) The role of modulatory calcineurin-interacting proteins in calcineurin signaling. Trends Cardiovasc Med 13:15-21
22. Ruskoaho H (1992) Atrial natriuretic peptide: Synthesis, release, and metabolism. Pharmacol Rev 44:479-602
23. Schubert A, Walther T, Falk V, Binner C, Löscher N, Kanev A, Bleiziffer S, Rauch T, Autschbach R, Mohr FW (2001) Extracellular matrix gene expression correlates to left ventricular mass index after surgical induction of left ventricular hypertrophy. Basic Res Cardiol 96:381-387
24. Schwartz K, de la Bastie D, Bouveret P, Olivéro P, Alonso S, Buckingham M (1986) α-skeletal muscle actin mRNA's accumulate in hypertrophied adult rat hearts. Circ Res 59:551-555
25. Stemmer PM, Klee CB (1994) Dual calcium ion regulation of calcineurin by calmodulin and calcineurin B. Biochemistry 33:6859-6866
26. Taigen T, de Windt LJ, Lim HW, Molkentin JD (2000) Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy. Proc Natl Acad Sci USA 97:1196-1201
27. Wilkins BJ, Dai YS, Bueno OF, Parsons SA, Xu J, Plank DM, Jones F, Kimball TR, Molkentin JD (2004) Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res 94:110-118
28. Wilkins BJ, de Windt LJ, Bueno OF, Braz JC, Glascock BJ, Kimball TF, Molkentin JD (2002) Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth. Mol Cell Biol 22:7603-7613
29. Wilkins BJ, Molkentin JD (2004) Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophys Res Commun 322:1178-1191